Serum Institute of India, Bharat Biotech producing minimum 8 crore doses/month, yet only 5 crore will be given by May-end

Credit: IndiaTimes- Published on May 23, 2021
The government in an affidavit in the Supreme Court earlier this month averred that Serum Institute of India (SII) was producing 6.5 crore doses of Covishield a month and Bharat Biotech was producing 2 crore doses of Covaxin a month, which was to be enhanced to 5.5 crore doses a month by July. It also said Sputnik was expected to...

You are here

💡 newsR Knowledge: Other News Mentions

Supreme Court of the United States

Highest court in the United States
PhD scholar Praveen Kumar s covering a distance of over 200km on foot to reach the apex court with a petition to “reclaim his honour” after his name figured,..
Credit: IndiaTimes - Published 28 minutes ago

Privileges bestowed upon elected members of the legislature are not a “mark of status” which makes them stand on an unequal pedestal, the Supreme Court said..
Credit: IndiaTimes - Published 5 hours ago

Both houses of Parliament were adjourned for the day on Wednesday as the opposition got united and demanded a debate on the Pegasus spyware issue in the presence..
Credit: IndiaTimes - Published 8 hours ago

"I want to know from the youth of the country - Narendra Modi Ji has sent a weapon in your phone. This weapon has been used against me, Supreme Court, many..
Credit: IndiaTimes - Published 12 hours ago

Oxford–AstraZeneca COVID-19 vaccine

Vaccine against COVID-19
Covishield generated 93% protection against Covid, whereas mortality due to the infection came down by 98% during the second wave which was driven by Delta..
Credit: IndiaTimes - Published 1 day ago

A study by Armed Forces Medical Services (AFMS) has found that Covishield vaccine reduces fresh COVID-19 infections by 93 per cent and deaths by 98 per cent, the..
Credit: IndiaTimes - Published 1 day ago

The recommendation of an expert panel on Covid to increase the gap between Covishield doses was made based on scientific evidence in a transparent manner, the..
Credit: IndiaTimes - Published 1 day ago


Vaccine against COVID-19
After closing the emergency use authorisation (EUA) and Phase-3 clinical trials requests for Bharat Biotech’s Covaxin, Brazil’s health regulator Anvisa..
Credit: IndiaTimes - Published 10 hours ago

After suspending the clinical trials of Covaxin following the termination of Bharat Biotech's MoU with its Brazilian partner Precisa Medicamentos, Brazil’s..
Credit: IndiaTimes - Published 2 days ago

In view of a probable third wave of the pandemic, vaccination trials on children have been underway in India with Covaxin and Zydus Cadila's ZyCov-D.
Credit: DNA - Published 5 days ago

Bharat Biotech on Friday said it has committed to supply over 500 million doses of its COVID-19 vaccine Covaxin to the Centre under the countrywide immunisation..
Credit: IndiaTimes - Published 5 days ago

Related videos from verified sources

Covid-19: Govt panel suggests 'two Covidshield jab gap be increased to 12-16 weeks'| Oneindia News 01:09
Credit: Oneindia - Published on May 13, 2021 

Bharat Biotech responds to Delhi's Covaxin plea, says...| Oneindia News 03:17
Credit: Oneindia - Published on May 12, 2021 

Around 1 lakh people died during COVID 2nd wave: Sisodia slams Centre over vaccine export 02:05
Credit: ANI - Published on May 9, 2021 

Related news from verified sources

The government in an affidavit in the Supreme Court earlier this month averred that Serum Institute of India (SII) was producing 6.5 crore doses of Covishield a...
on May 23, 2021 • IndiaTimes

The government on Monday said it had paid an advance of over Rs 2,500 crore to Serum Institute of India and Bharat Biotech for supply of 16 crore doses of Covid...
on May 3, 2021 • IndiaTimes

 The Pune-based Serum Institute of India (SII) has ramped up production of COVID-19 vaccine and will provide 10 crore doses of Covishield to the Centre by the...
on May 30, 2021 • Zee News

You might like